Form 4: Hologic Director Ludwig Hantson Reports Acquisition of Stock and Stock Options

Director Ludwig Hantson reports acquisition of common stock and stock options in Hologic Inc.

Summary

• On February 26, 2025, Ludwig Hantson, a director of Hologic Inc., reported acquiring 1,864 shares of common stock.
• These shares were obtained through the acquisition of restricted stock units (RSUs) that vest on the date of the 2026 Annual Meeting of Stockholders and are settled in shares of common stock on a one-for-one basis.
• Hantson also acquired 5,535 non-qualified stock options with an exercise price of $64.36, which become exercisable on the date of the 2026 Annual Meeting of Stockholders and expire on February 26, 2035.
• Following these transactions, Hantson beneficially owns 12,956 shares of common stock, including 3,695 restricted stock units with deferred settlement.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard SEC filing detailing stock and option acquisitions by a director. It doesn't inherently indicate positive or negative sentiment, but rather provides transparency into insider transactions.

Positives

• The acquisition of shares and stock options by a director could be seen as a positive signal, indicating confidence in the company's future performance.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting and exercisability of the acquired securities are tied to the 2026 Annual Meeting of Stockholders.

Industry Context

This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. Investors often monitor these filings for signals about management's confidence in the company's prospects.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment if viewed as a sign of confidence from a company director.

Next Steps

• Monitor future filings to track changes in insider ownership.
• Observe the company's performance leading up to the 2026 Annual Meeting of Stockholders, as the vesting and exercisability of the securities are tied to this event.

Key Dates